July 13, 2026

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 36.61% Potential Upside in a Competitive Market

Prestige Consumer Healthcare Inc. (NYSE: PBH), a formidable player in the healthcare sector, has captured investor attention with its diverse portfolio of over-the-counter health and personal care products. Headquartered in..

Telix Pharmaceuticals Limited (TLX): Analyst Consensus and Growth Potential with an 87% Upside

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biotechnology sector, is capturing investor attention with its impressive growth trajectory and significant upside potential. Headquartered in North Melbourne, Australia,..

Tempus AI, Inc. (TEM) Stock Report: Navigating Growth Amid a 13.45% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM) is fast becoming a focal point for investors keen on the intersection of healthcare and technology. With a market capitalization of $10.46 billion, the company..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Examining a Healthcare Leader with 11.68% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO) stands as a stalwart in the healthcare sector, specializing in medical instruments and supplies. With a rich history dating back to 1853, the company..

Encompass Health Corporation (EHC) Stock Analysis: A Compelling 27.54% Upside Potential

Encompass Health Corporation (NYSE: EHC), a leading player in the healthcare sector, specifically in medical care facilities, is drawing significant attention from investors due to its robust growth potential and..

RadNet, Inc. (RDNT) Stock Analysis: A Compelling 36.81% Potential Upside for Investors

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, specifically in diagnostics and research, presents a promising opportunity for investors seeking growth in the medical imaging industry. With..

West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Giant with a 21% Revenue Growth and Solid Analyst Ratings

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a substantial market capitalization of $24.99..

Elanco Animal Health (ELAN) Stock Analysis: Analyst Consensus Signals 20% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $12.4..

Tenet Healthcare Corporation (THC) Stock Analysis: A Healthcare Giant with Strong Buy Ratings and 19.55% Upside Potential

Tenet Healthcare Corporation (NYSE: THC), a stalwart in the healthcare sector, is making waves with its robust position in the medical care facilities industry. With a market capitalization of $17.59..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Navigating a 22% Potential Upside in the Medical Devices Sector

GE HealthCare Technologies Inc. (NYSE: GEHC), a stalwart in the healthcare sector, particularly within the medical devices industry, presents an intriguing opportunity for investors seeking growth and stability. With a..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Titan with a Promising 7.17% Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) stands out in the biotechnology landscape, driven by its pioneering approach to developing targeted therapies for RAS-addicted cancers. The company’s robust portfolio and strategic positioning..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring the 9.47% Upside Potential in Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV), a trailblazer in the biotechnology industry, is captivating investor attention with its robust pipeline and a promising potential upside of 9.47%. Based in London, this..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring an 87.99% Potential Upside in Biotechnology

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, offers investors a combination of potential high reward and significant risk. With a market capitalization of $11.84 billion,..

BioNTech SE (BNTX) Stock Analysis: Navigating a 33% Upside Potential Amidst Revenue Challenges

In the ever-evolving biotechnology sector, BioNTech SE (NASDAQ: BNTX) presents a compelling investment case with its diverse portfolio of immunotherapies and a significant potential upside of 33.08%. Based in Mainz,..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and Potential Upside Amid Robust Revenue Growth

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a prominent player in the biotechnology sector, making waves with its innovative pharmaceutical products and promising pipeline. Headquartered in Dublin, Ireland, the company has..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Amidst a Challenging Valuation Landscape

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a key player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $11.24 billion,..

Biogen Inc. (BIIB) Stock Analysis: Navigating a Robust Pipeline with 11.89% Upside Potential

Biogen Inc. (NASDAQ: BIIB) stands as a towering figure in the healthcare sector, with its extensive portfolio of therapies spanning multiple sclerosis, neurological diseases, and other complex conditions. As of..

ResMed Inc. (RMD) Stock Analysis: Navigating a 25.60% Potential Upside Amidst Strong Healthcare Sector Growth

ResMed Inc. (NYSE: RMD), a significant player in the healthcare sector, stands at the forefront of the medical instruments and supplies industry with a market capitalization of $29.57 billion. The..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Healthcare Standout with Robust Revenue Growth

TG Therapeutics, Inc. (NASDAQ: TGTX) has emerged as a noteworthy player in the healthcare sector, specifically in the biotechnology industry. With a market capitalization of $8.74 billion, this American company..

Revvity, Inc. (RVTY) Stock Analysis: Navigating Growth with a 7% Revenue Rise and Analyst Insights

Revvity, Inc. (NASDAQ: RVTY), a prominent player in the healthcare sector specializing in diagnostics and research, has been making waves with its recent financial performance and market movements. With a..

Search

Funds

July 13, 2026

Search

Funds

July 13, 2026

FTSE 100

Funds